Status | Study |
Completed |
Study Name: Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease Condition: Cold Agglutinin Disease Autoimmune Hemolytic Anemia Date: 2016-02-16 Interventions: Drug: Bendamustine, Rituximab Bendamustine, Rituximab |
Recruiting |
Study Name: Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders Condition: Bullous Pemphigoid (BP) Cold Agglutinin Disease Date: 2015-07-07 Interventions: Drug: TNT009 Other: Placebo |
Active, not recruiting |
Study Name: Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease Condition: Refractory Cold Agglutinin Disease Date: 2012-09-27 Interventions: Drug: Bortezomib |
Completed |
Study Name: Therapy of Chronic Cold Agglutinin Disease With Eculizumab Condition: Cold Agglutinin Disease Date: 2011-02-24 Interventions: Drug: Eculizumab Weekly treatment with eculizumab (600 mg) via IV infusion for 4 doses followed the next |
Completed |
Study Name: The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders Condition: Pemphigus Auto-immune Thrombocytopenic Purpura Hemolytic A Date: 2009-07-16 Interventions: Drug: Rituximab (MABTHERA® or RITUXAN®). patients can be included in the study whatever the do |
Completed |
Study Name: Therapy for Chronic Cold Agglutinin Disease Condition: Cold Agglutinin Disease Date: 2006-09-07 Interventions: Drug: Rituximab Drug: Fludarabine |